NCT02393547View on ClinicalTrials.gov

Lorcaserin for Preventing Weight Gain Among Smokers

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Tobacco Use DisorderWeight Gain

Interventions

DRUG

Varenicline

All subjects receive Varenicline

DRUG

Lorcaserin

All subjects receive Lorcaserin

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER